BIOMX.COM: Keyword Density Checker

Total words: 2257 | 2-word phrases: 592 | 3-word phrases: 648 | 4-word phrases: 666

PAGE INFO

Title	Try to keep the title under 60 characters (21 characters) BiomX \| Phage therapy
Description	Try to keep the meta description between 50 - 160 characters (100 characters) Developing natural and engineered phage therapies to eradicate harmful bacteria in chronic diseases.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	entered into a	3	0.46%
2	see press release	3	0.46%
3	have entered into	3	0.46%
4	we have entered	3	0.46%
5	to negotiate an	2	0.31%
6	press release utilizes	2	0.31%
7	with us on	2	0.31%
8	us on linkedin	2	0.31%
9	advancing medicine precisely	2	0.31%
10	exclusive right to	2	0.31%
11	an exclusive right	2	0.31%
12	negotiate an exclusive	2	0.31%
13	bacteria in chronic	2	0.31%
14	ingelheim to negotiate	2	0.31%
15	diabetic foot osteomyelitis	2	0.31%
16	harmful bacteria in	2	0.31%
17	inflammatory bowel disease	2	0.31%
18	in chronic diseases	2	0.31%
19	platform to potentially	2	0.31%
20	terms of the	2	0.31%
21	the terms of	2	0.31%
22	xmarker microbiomebased biomarker	2	0.31%
23	microbiomebased biomarker discovery	2	0.31%
24	biomarker discovery platform	2	0.31%
25	boehringer ingelheim to	2	0.31%
26	discovery platform to	2	0.31%
27	directors scientific founders	2	0.31%
28	entered into two	2	0.31%
29	of directors scientific	2	0.31%
30	technology bacteriophage background	2	0.31%

#	Keyword	Frequency	Density
1	we have entered into	3	0.45%
2	phage therapy biomarker discovery	2	0.30%
3	biomarker discovery platform to	2	0.30%
4	microbiomebased biomarker discovery platform	2	0.30%
5	xmarker microbiomebased biomarker discovery	2	0.30%
6	bacteria in chronic diseases	2	0.30%
7	harmful bacteria in chronic	2	0.30%
8	into two collaborations with	2	0.30%
9	entered into two collaborations	2	0.30%
10	have entered into two	2	0.30%
11	see press release utilizes	2	0.30%
12	with us on linkedin	2	0.30%
13	ingelheim to negotiate an	2	0.30%
14	the terms of the	2	0.30%
15	company executive team board	2	0.30%
16	boehringer ingelheim to negotiate	2	0.30%
17	negotiate an exclusive right	2	0.30%
18	an exclusive right to	2	0.30%
19	to negotiate an exclusive	2	0.30%
20	of directors scientific founders	2	0.30%
21	in the company intended	1	0.15%
22	presentation updated may 2024	1	0.15%
23	corporate presentation updated may	1	0.15%
24	biomx’s corporate presentation updated	1	0.15%
25	bx005 biomx’s corporate presentation	1	0.15%
26	of bx005 biomx’s corporate	1	0.15%
27	study of bx005 biomx’s	1	0.15%
28	support the phase 12	1	0.15%
29	to support the phase	1	0.15%
30	primarily to support the	1	0.15%
31	intended primarily to support	1	0.15%
32	company intended primarily to	1	0.15%
33	the company intended primarily	1	0.15%
34	investment in the company	1	0.15%
35	and events view all	1	0.15%
36	agreement for an equity	1	0.15%
37	inc receives notice of	1	0.15%
38	receives notice of noncompliance	1	0.15%
39	notice of noncompliance with	1	0.15%
40	binding agreement for an	1	0.15%